Selective Expression of Purkinje-Cell Antigens in Tumor Tissue from Patients with Paraneoplastic Cerebellar Degeneration
Open Access
- 28 June 1990
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (26) , 1844-1851
- https://doi.org/10.1056/nejm199006283222604
Abstract
Paraneoplastic cerebellar degeneration is a rare syndrome that occurs in patients with gynecologic cancer and is characterized by widespread loss of Purkinje cells. To determine whether Purkinje-cell antigens are selectively expressed in the tumors of patients with the syndrome, we examined tumor tissue from 10 patients whose serum contained anti—Purkinje-cell (anti-Yo) antibodies. The origins of the cancers were the breast (five patients), ovary (three), endometrium (one), and fallopian tube (one). We used as controls tumor tissue from 11 patients with ovarian cancer and 10 patients with breast cancer who were neurologically normal. Using immunohistochemical and Western blot analysis, we found that Purkinje-cell antigens were expressed in all the tumors from the 10 patients with paraneoplastic cerebellar degeneration but in none of the tumors from the 21 neurologically normal patients. When IgG from patients with paraneoplastic cerebellar degeneration was affinity-purified to cerebellar Purkinje-cell antigen, immunohistochemical analysis showed that it reacted specifically with the tumor tissue from those patients. We conclude that in patients with paraneoplastic cerebellar degeneration, the anti-Yo antibody results from an immune response to neural antigens expressed by the gynecologic tumors in the patients. (N Engl J Med 1990; 322:1844–51.)This publication has 26 references indexed in Scilit:
- Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse.Proceedings of the National Academy of Sciences, 1990
- Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.Proceedings of the National Academy of Sciences, 1989
- Paraneoplastic cerebellar degeneration: Clinical‐immunological correlationsAnnals of Neurology, 1988
- Autoimmune paraneoplastic cerebellar degenerationNeurology, 1988
- Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.Proceedings of the National Academy of Sciences, 1987
- Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degenerationNeurology, 1986
- Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigenAnnals of Neurology, 1985
- Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinomaAnnals of Neurology, 1983
- A method for separation of Purkinje cell- and granular cell-enriched fractions from rabbit cerebellumBrain Research, 1973
- SUBACUTE CEREBELLAR DEGENERATION ASSOCIATED WITH NEOPLASMSBrain, 1965